Doxorubicin-Dacarbazine
Administration
• Both Doxorubicin and Dacarbazine are administered intravenously (IV, meaning through the veins), typically in a hospital setting or chemotherapy day unit.
• Different delivery methods, including cannulas, central lines, PICC lines, or implantable ports, are tailored to individual patient needs.
• Treatment may be given over the course of 3-5 days every 21 days, which defines 1 cycle.
• A multidisciplinary team, including a cancer doctor, chemotherapy nurse, and specialist pharmacist, oversees the administration.
• Before treatment, a blood sample is taken to ensure safe blood cell levels for chemotherapy.
• You may receive oral or IV drugs prior and after the infusion to prevent nausea.
• It is possible that a subcutaneous injection is required following each cycle. Given at home or at the clinic, it will help boost the immune system.
• Imaging is usually repeated every 2-3 cycles to determine the response.
• The number of cycles of treatment will depend on your tolerance to treatment and your response.
Potential Side Effects & Management
While treatment is being given:
• Allergic Reactions: Signs include feeling hot, itching, rash, dizziness, or swelling. Prompt identification and treatment are crucial.
• Extravasation: Drug leakage outside the vein is critical for sarcoma patients. It can impact surrounding tissues, warranting urgent intervention. Immediate reporting of stinging, pain, redness, or swelling around the vein is essential.
• Pain along the vein: Treatment may cause pain at the infusion site. Promptly inform your nurse or doctor for assessment. Adjustments in drug administration speed or dilution may alleviate pain.
• Facial Flushing: A temporary warm, red sensation during drug administration.
Common Side Effects:
• Infection Risk: Given sarcoma treatments’ intensity, reduced white blood cell counts heighten infection risks, necessitating vigilance and timely medical intervention. If you have a fever over 38.3°C, you should advise your medical team or go to the emergency department.
• Bruising and Bleeding: Reduced platelets due to treatment can lead to easy bruising, nosebleeds, or blood in urine/stool. Platelet transfusion might be necessary.
• Anemia: Reduced red blood cells due to treatment can cause anemia. If severe, blood transfusion might be necessary.
• Nausea and Hair Loss: Managing these side effects can significantly impact quality of life during treatment.
• Loss of Appetite: Treatment can impact appetite temporarily. Dietary changes may be suggested.
• Diarrhea: Increased bowel activity; more common if you have a stoma.
• Constipation: inability to pass stools as often as usual. Management includes drinking a lot of fluids, increasing fiber consumption, light exercise, and in severe cases, laxatives may be prescribed.
• Sore Mouth & Throat: Treatment may cause sore mouth and throat which can potentially lead to mouth ulcers and increased risk of infection. Maintain oral hygiene; contact your healthcare team for mouthwash or medicines if needed.
• Skin Changes: Rash, sensitivity, discoloration; moisturizing and protective measures are recommended.
• Sore and Red Palms, Soles: Palmar-plantar syndrome causes redness and peeling. Keep hands and feet cool, moisturize, and avoid tight-fitting items.
• Nail Changes: Slower nail growth, breakage, ridges, or discoloration may be experienced. Moisturize nails, keep them short, wear protective gloves.
• Liver Impact: Potential mild effects on liver function; regular blood tests will monitor liver performance.
• Fatigue: This treatment may cause fatigue or weakness, which can impact daily activities.
Less Common Side Effects:
• Sore Eyes and Sensitivity to the Sun: Watery eyes and discomfort may occur, treated with prescribed eye drops; inform your doctor if redness develops (conjunctivitis).
• Flu-like Symptoms: Dacarbazine treatment may induce flu-like symptoms such as headaches and muscle or joint pain, which can be managed with medication and adequate hydration, but severe or persistent symptoms should prompt contacting the hospital.
• Cardiac and Organ Health: Regular cardiac monitoring and blood tests are imperative for patients on Doxorubicin due to potential cumulative effects.
Precautionary Measures for Sarcoma Patients
• Blood clot risk: Report symptoms like swelling, breathlessness, or sharp chest pain immediately.
• Communication: Always prioritize informing your healthcare team about ongoing sarcoma treatments, ensuring coordinated care and potential adjustments.
• Vaccinations: Sarcoma patients should be aware of vaccination recommendations, especially considering treatment impacts on immune responses.
• Sex and Contraception: This treatment may impact fertility; discuss and plan contraception strategies with your oncologists.
• Breastfeeding: Avoid while having treatment.
Understanding the details of this treatment, including its administration, potential side effects, and precautionary measures, empowers patients to actively participate in their care and optimize treatment outcomes. Always communicate openly with your healthcare team for personalized guidance and support.